AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2017

Jun 26, 2017

Director's Dealing

Opens in your device viewer

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 26. June 2017) Rolf E. Engstad, CSO of Biotec BetaGlucans has on 23.

June purchased 20 000 shares in Biotec Pharmacon at NOK 5.50 per share. After

this transaction holds Engstad 370.774 shares and 80.000 options in Biotec

Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187